DK460387A - Sammensaetning, der er i stand til at frembringe et immunologisk respons i et pattedyr paa en udvalgt epitop - Google Patents
Sammensaetning, der er i stand til at frembringe et immunologisk respons i et pattedyr paa en udvalgt epitopInfo
- Publication number
- DK460387A DK460387A DK460387A DK460387A DK460387A DK 460387 A DK460387 A DK 460387A DK 460387 A DK460387 A DK 460387A DK 460387 A DK460387 A DK 460387A DK 460387 A DK460387 A DK 460387A
- Authority
- DK
- Denmark
- Prior art keywords
- mammal
- generating
- composition capable
- immunological response
- selected epitope
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6075—Viral proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
- A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12311—Rotavirus, e.g. rotavirus A
- C12N2720/12322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US90322286A | 1986-09-03 | 1986-09-03 | |
US90322286 | 1986-09-03 |
Publications (3)
Publication Number | Publication Date |
---|---|
DK460387D0 DK460387D0 (da) | 1987-09-03 |
DK460387A true DK460387A (da) | 1988-03-04 |
DK171602B1 DK171602B1 (da) | 1997-02-17 |
Family
ID=25417135
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK460387A DK171602B1 (da) | 1986-09-03 | 1987-09-03 | Sammensætning, der er i stand til at frembringe et immunologisk respons i et pattedyr på en udvalgt epitop, vaccinesammensætning som omfatter molekyler, der bærer den givne epitop, og fremgangsmåde til fremstilling af vaccinen |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0259149B1 (da) |
JP (1) | JPS63218627A (da) |
AT (1) | ATE98493T1 (da) |
AU (1) | AU608769B2 (da) |
CA (1) | CA1319101C (da) |
DE (1) | DE3788475T2 (da) |
DK (1) | DK171602B1 (da) |
ES (1) | ES2060603T3 (da) |
IE (1) | IE61417B1 (da) |
IL (1) | IL83755A (da) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6086880A (en) * | 1985-12-26 | 2000-07-11 | The University Of Saskatchewan | Rotavirus peptide compositions and methods of use |
CA1340530C (en) * | 1989-04-28 | 1999-05-04 | Kok Kheong Lee | Synthetic pseudomonas aeruginosa pilin peptide and related vaccines and diagnostics |
GB9000143D0 (en) * | 1990-01-04 | 1990-03-07 | Natural Environment Res | Test kit and method for the diagnosis of bluetongue |
US5298244A (en) * | 1990-10-25 | 1994-03-29 | University Of Saskatchewan | Assembled viral particles and their use in a vaccine to rotaviral disease |
US5431899A (en) * | 1991-02-04 | 1995-07-11 | University Of Saskatchewan | Rotavirus VP6 as a diagnostic and targeting agent |
JPH06506667A (ja) * | 1991-02-04 | 1994-07-28 | ユニバーシティ オブ サスカチェワン | カプセル化したvp6の薬物送達 |
CA2162557C (en) | 1993-05-12 | 2004-09-28 | Amy J. Weiner | Conserved motif of hepatitis c virus e2/ns1 region |
US5820868A (en) | 1993-12-09 | 1998-10-13 | Veterinary Infectious Disease Organization | Recombinant protein production in bovine adenovirus expression vector system |
US6150137A (en) | 1994-05-27 | 2000-11-21 | Ariad Pharmaceuticals, Inc. | Immunosuppressant target proteins |
US6777217B1 (en) | 1996-03-26 | 2004-08-17 | President And Fellows Of Harvard College | Histone deacetylases, and uses related thereto |
DE19618797C2 (de) * | 1996-05-10 | 2000-03-23 | Bertling Wolf | Vehikel zum Transport molekularer Substanz |
AU750702B2 (en) * | 1997-05-01 | 2002-07-25 | Chiron Corporation | Use of virus-like particles as adjuvants |
ATE377087T1 (de) | 1997-06-23 | 2007-11-15 | Univ Saskatchewan | Verfahren zur herstellung eines rekombinanten rinderadenovirus-vektors |
DE19750354A1 (de) * | 1997-11-13 | 1999-05-27 | November Ag Molekulare Medizin | Verfahren zur Applikation von Wirkstoffen |
US6492343B1 (en) | 1998-04-15 | 2002-12-10 | University Of Saskatchewan | Porcine adenovirus type 3 genome |
DE19829005C2 (de) * | 1998-06-29 | 2000-08-31 | November Ag Molekulare Medizin | Verfahren zum Transport molekularer Substanz in vorgegebene Bereiche eukaryontischer Zellen |
EP1127151A2 (en) | 1998-11-02 | 2001-08-29 | University of Saskatchewan | Bovine cells expressing adenovirus essential functions for propagation of recombinant adenoviral vectors |
JP2010510960A (ja) | 1998-11-30 | 2010-04-08 | サイトス バイオテクノロジー アーゲー | 抗原の順序付けられた分子提示、提示の方法、および使用 |
US6451319B1 (en) | 1999-04-09 | 2002-09-17 | Schering-Plough Veterinary Corporation | Recombinant and mutant adenoviruses |
US6299882B1 (en) | 1999-04-09 | 2001-10-09 | Schering Corporation | UL54.5 of Marek's disease virus (MDV) |
DE19916224C1 (de) | 1999-04-10 | 2000-06-21 | November Ag Molekulare Medizin | Synthetisches biologisch aktives Molekül |
US7396905B1 (en) | 1999-05-21 | 2008-07-08 | Mckeon Frank | Calcipressins: endogenous inhibitors of calcineurin, uses and reagents related thereto |
EP1287162A2 (en) | 1999-10-21 | 2003-03-05 | Case Western Reserve University | Gene expression profiling of inflammatory bowel disease |
US20030129724A1 (en) | 2000-03-03 | 2003-07-10 | Grozinger Christina M. | Class II human histone deacetylases, and uses related thereto |
AU2001252458A1 (en) | 2000-05-05 | 2001-11-20 | Martin Bachmann | Molecular antigen arrays and vaccines |
CA2410665C (en) | 2000-05-31 | 2017-11-07 | University Of Saskatchewan | Modified bovine adenovirus having altered tropism |
US7128911B2 (en) | 2001-01-19 | 2006-10-31 | Cytos Biotechnology Ag | Antigen arrays for treatment of bone disease |
US7094409B2 (en) | 2001-01-19 | 2006-08-22 | Cytos Biotechnology Ag | Antigen arrays for treatment of allergic eosinophilic diseases |
US7320793B2 (en) | 2001-01-19 | 2008-01-22 | Cytos Biotechnology Ag | Molecular antigen array |
US7244853B2 (en) | 2001-05-09 | 2007-07-17 | President And Fellows Of Harvard College | Dioxanes and uses thereof |
US7569217B2 (en) | 2001-09-24 | 2009-08-04 | University Of Saskatchewan | Porcine adenovirus E1 and E4 regions |
US7115266B2 (en) | 2001-10-05 | 2006-10-03 | Cytos Biotechnology Ag | Angiotensin peptide-carrier conjugates and uses thereof |
EP1532167B1 (en) | 2002-07-17 | 2012-01-25 | Cytos Biotechnology AG | Molecular antigen arrays using a virus like particle derived from the ap205 coat protein |
KR101228376B1 (ko) | 2002-07-18 | 2013-01-31 | 사이토스 바이오테크놀로지 아게 | 합텐-캐리어 컨쥬게이트 및 그의 용도 |
JP4644488B2 (ja) | 2002-07-19 | 2011-03-02 | サイトス・バイオテクノロジー・アクチェンゲゼルシャフト | アミロイドベータ1−6抗原アレイを含むワクチン組成物 |
AU2003255967A1 (en) | 2002-07-19 | 2004-02-09 | University Of Saskatchewan | Pav regions for encapsidation and e1 transcriptioonal control |
US7264818B2 (en) | 2003-06-10 | 2007-09-04 | University Of Saskatchewan | BAV packaging regions and E1 transcriptional control regions |
EP1784220B1 (en) | 2004-08-26 | 2017-12-20 | The University Of Western Ontario | Bacterial iron acquisition targets |
CA2601706C (en) | 2005-03-22 | 2016-09-20 | Dana-Farber Cancer Institute, Inc. | Treatment of protein degradation disorders |
EP2224008A3 (en) | 2005-05-12 | 2010-12-01 | Murdoch University | Genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy |
WO2007059166A2 (en) | 2005-11-14 | 2007-05-24 | Weber Georg F | Peptide sequence that promotes tumor invasion |
CN101400362B (zh) | 2006-02-14 | 2016-10-12 | 哈佛大学校长及研究员协会 | 双官能组蛋白去乙酰化酶抑制剂 |
WO2007130429A2 (en) | 2006-05-03 | 2007-11-15 | The President And Fellows Of Harvard College | Histone deacetylase and tubulin deacetylase inhibitors |
US8992938B2 (en) | 2007-08-03 | 2015-03-31 | Matthew Bellgard | Genes and proteins of Brachyspira hyodysenteriae and uses thereof |
GB0720250D0 (en) | 2007-10-17 | 2007-11-28 | Univ Edinburgh | Immunogenic compositions containing escherichia coli h7 flagella and methods of use thereof |
EP2363407A1 (en) | 2008-02-28 | 2011-09-07 | Murdoch University | Novel sequences of Brachyspira, immunogenic compositions, methods for preparation and use thereof |
EP2271664A4 (en) | 2008-03-27 | 2011-11-23 | Prionics Ag | NEW SEQUENCES OF BRACHYSPIRA, IMMUNOGENIC COMPOSITION, METHOD OF MANUFACTURE AND APPLICATION THEREOF |
AU2009274549B2 (en) | 2008-07-23 | 2014-05-01 | Dana-Farber Cancer Institute, Inc. | Deacetylase inhibitors and uses thereof |
US8716344B2 (en) | 2009-08-11 | 2014-05-06 | President And Fellows Of Harvard College | Class- and isoform-specific HDAC inhibitors and uses thereof |
CN111569056B (zh) * | 2020-05-26 | 2022-09-27 | 山东信得科技股份有限公司 | 一种猪轮状病毒疫苗、制备该疫苗的抗原及其编码序列 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0235391B1 (en) * | 1985-12-26 | 1992-06-10 | The University of Saskatchewan | Peptides corresponding to antigenic and immunogenic determinants of major neutralizing proteins of rotaviruses |
US5186933A (en) * | 1986-12-30 | 1993-02-16 | Baylor College Of Medicine | Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system |
-
1987
- 1987-09-01 CA CA000545803A patent/CA1319101C/en not_active Expired - Fee Related
- 1987-09-02 IE IE235387A patent/IE61417B1/en not_active IP Right Cessation
- 1987-09-02 EP EP87307746A patent/EP0259149B1/en not_active Expired - Lifetime
- 1987-09-02 DE DE87307746T patent/DE3788475T2/de not_active Expired - Fee Related
- 1987-09-02 ES ES87307746T patent/ES2060603T3/es not_active Expired - Lifetime
- 1987-09-02 AT AT87307746T patent/ATE98493T1/de active
- 1987-09-02 IL IL83755A patent/IL83755A/xx not_active IP Right Cessation
- 1987-09-03 AU AU77918/87A patent/AU608769B2/en not_active Ceased
- 1987-09-03 JP JP62221818A patent/JPS63218627A/ja active Pending
- 1987-09-03 DK DK460387A patent/DK171602B1/da not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IE872353L (en) | 1988-03-03 |
EP0259149A2 (en) | 1988-03-09 |
IE61417B1 (en) | 1994-11-02 |
IL83755A (en) | 1993-04-04 |
EP0259149A3 (en) | 1989-05-24 |
DE3788475D1 (de) | 1994-01-27 |
DK460387D0 (da) | 1987-09-03 |
AU7791887A (en) | 1988-03-10 |
CA1319101C (en) | 1993-06-15 |
ATE98493T1 (de) | 1994-01-15 |
AU608769B2 (en) | 1991-04-18 |
EP0259149B1 (en) | 1993-12-15 |
DK171602B1 (da) | 1997-02-17 |
JPS63218627A (ja) | 1988-09-12 |
IL83755A0 (en) | 1988-02-29 |
ES2060603T3 (es) | 1994-12-01 |
DE3788475T2 (de) | 1994-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK460387A (da) | Sammensaetning, der er i stand til at frembringe et immunologisk respons i et pattedyr paa en udvalgt epitop | |
ATE47155T1 (de) | Monoklonaler antikoerper. | |
JPS5214694A (en) | Polytriazine with high molecular weight | |
JPS5282049A (en) | Control system for information alternation of terminal equipment | |
JPS5214695A (en) | Polytriazine with high molecular weight | |
DK134651B (da) | Substrat til bestemmelse af desoxyribonuclease og dettes antistoffer, indeholdende et kompleks af hojmolekyler desoxyribonucleinsyre og et farvestof, samt fremgangsmade til fremstilling af dette substrat | |
IT1126709B (it) | Procedimento di candeggio ottico per substrati costituiti,in parte o in totalita',da poliammidi sintetiche | |
DK139432B (da) | Analogifremgangsmåde til fremstilling af indol(2,3-a)kinolizidinderivater. | |
CA946537A (en) | Modified high molecular weight polyamides with high affinity for acid dyes | |
ES245420U (es) | Recipiente de metal en especial para gas a presion | |
SU524991A1 (ru) | Стенд дл испытани ведущих мостов транспортных средств | |
SU938063A1 (ru) | Стенд дл испытани транспортных средств | |
SU605975A1 (ru) | Междуэтажна крепь | |
AU534486B2 (en) | 4,5,5a,6-tetrahydro-dibenz(cd,f)indoles | |
Barkin | Analysis Symposium: Webern, Orchestra Pieces (1913) Movement I (" Bewegt") | |
SU592005A2 (ru) | Баланснный модул тор | |
IT7922021A0 (it) | Coloranti reattivi antrachinonici. | |
JPS51140702A (en) | Semiconductor laser pickup apparatus | |
SU608653A2 (ru) | Устройство дл выделени полимерных материалов из их растворов | |
GR3006212T3 (da) | ||
SU658500A1 (ru) | Цифровой фазометр | |
SU596370A1 (ru) | Стенд дл ремонта ковшей | |
JPS5273458A (en) | Derrick loading system | |
JPS51118448A (en) | Polarizing prism | |
JPS5236185A (en) | Preparation of novel reactive polymer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B1 | Patent granted (law 1993) | ||
PBP | Patent lapsed |